InMed Pharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
InMed Pharmaceuticals Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 3.57% of the total amount of its stocks outstanding. This makes up a total of 82.07K shares of InMed Pharmaceuticals Inc.. Compared to the previous quarter, the number fell by -29.13% or -33.73K shares fewer. As for the holding position changes, 22.22% (2) of current hedge fund investors increased the number of shares held, and 11.11% (1) closed the holdings completely. 3 hedge funds are new holders of InMed Pharmaceuticals Inc. stock in Q1 2023, it is 33.33% of total holders.
Hedge funds holding InMed Pharmaceuticals (Q4 2020 – Q1 2023)
Q4 2020 | 10 |
---|---|
Q1 2021 | 15 |
Q2 2021 | 12 |
Q3 2021 | 10 |
Q4 2021 | 9 |
Q1 2022 | 10 |
Q2 2022 | 6 |
Q3 2022 | 7 |
Q4 2022 | 10 |
Q1 2023 | 9 |
Hedge funds changes in InMed Pharmaceuticals positions (Q4 2020 – Q1 2023)
Q4 2020 | 10 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q1 2021 | 5 | 4 | 0 | 0 | 6 |
Q2 2021 | 1 | 3 | 4 | 4 | 0 |
Q3 2021 | 2 | 2 | 2 | 4 | 0 |
Q4 2021 | 5 | 0 | 2 | 6 | -4 |
Q1 2022 | 4 | 1 | 2 | 2 | 1 |
Q2 2022 | 2 | 1 | 1 | 6 | -4 |
Q3 2022 | 7 | 0 | 0 | 6 | -6 |
Q4 2022 | 7 | 1 | 2 | 4 | -4 |
Q1 2023 | 3 | 2 | 0 | 1 | 3 |
Top 50 hedge fund holders of InMed Pharmaceuticals Inc. (NASDAQ:INM)
Hedge fund | Value | Shares owned | Portfolio share |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 593K | 90K | 0.010% |
SABBY MANAGEMENT, LLC | 101K | 15.28K | 0.127% |
MILLENNIUM MANAGEMENT LLC Israel Englander | 91K | 13.92K | 0.000% |
BANK OF AMERICA CORP /DE/ | 45K | 6.77K | 0.000% |
UBS GROUP AG | 38K | 5.79K | 0.000% |
TOWER RESEARCH CAPITAL LLC (TRC) | 7K | 1.06K | 0.000% |
MORGAN STANLEY | 1K | 134 | 0.000% |
CREATIVE PLANNING | 0 | 0 | 0.000% |
TWO SIGMA ADVISERS, LP | 0 | 0 | 0.000% |
CITADEL ADVISORS LLC Ken Griffin | 0 | 0 | 0.000% |
GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0.000% |
RENAISSANCE TECHNOLOGIES LLC Jim Simons | 0 | 0 | 0.000% |
ARMISTICE CAPITAL, LLC | 0 | 0 | 0.000% |